Barclays Says IBM Has Room To Run: What Does The Chart Show? - IBM (NYSE:IBM)

IBM surges 30% as Barclays calls its software the SaaSpocalypse antidote

IBM surged 30% in May on Barclays overweight ($350 target): infrastructure software immune to AI disruption vs. SaaS due to switching costs. For tech leaders: defensible where AI increases value (compliance, integration); quantum $10B (Anderon) is future option.